Similarly to ACY-738, pharmacological inhibition of HDAC 6 by tubastatin A reverted axonal transport deficits in ALS patient-derived MNs with mutations for FUS and TDP-43 (Guo et al., 2017; Fazal et al., 2021). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.